TrialBlood advances2025

Outcomes with third-party virus-specific T cells after the use of single-antigen cell lines to predict HLA restriction.

Jeremy D Rubinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.